Information for Staff Members to Prepare for Vaccination

The below materials are intended to help you make an informed decision about the COVID-19 vaccines and include information about the safety and efficacy of the vaccines, side effects, information for vaccinators, and monitoring and reporting reactions post vaccination.

Information about the COVID-19 Vaccine

As you prepare for COVID-19 vaccination, please review the information in this flyer.

COVID-19 Vaccine Information for Staff Flyer
BILH Acknowledgement of Receipt of Vaccine

You will sign a BILH Acknowledgement of Receipt of Vaccine document for the specific vaccine that was administered to you.

BILH After You Receive the Vaccine: Side Effects

You will receive a document on what to watch for post vaccination, including side effects and severe reactions.

Pfizer and Moderna Post-Vaccination Side Effects
Vaccine Monitoring and Safety

It’s important to monitor your health following vaccination. If you have a reaction, there are multiple ways to report it.

  • Report to BILH
  • Report to the CDC and FDA through the Vaccine Adverse Event Reporting System (VAERS)
  • Report to the CDC through a voluntary program called v-safe, a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination
U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) Fact Sheets

These fact sheets contain information to help you understand the risks and benefits of the Pfizer and Moderna COVID-19 vaccines.

Moderna COVID-19 Vaccine

Moderna’s site provides information for recipients on what the vaccine is, who is getting it and a list of Frequently Asked Questions (FAQs).

Massachusetts COVID-19 Vaccine Safety and Efficacy Evaluation Task Force

The Task Force, convened by the Baker-Polito Administration and composed of Infectious Disease experts from the major academic hospitals across the Commonwealth and the Massachusetts Department of Public Health, provides an independent, non-governmental evaluation of each COVID-19 vaccine authorized under Emergency Use Authorization by the U.S. Food & Drug Administration.